gvtcx

Recombinant Antibodies in a Customer Made Formulation

Medicines and Healthcare Products Regulatory Agency Published 5 Mar 2015 Contracts Finder

key details

Value£100,001
Statusactive
Category (CPV) 38000000
Deadline25 Mar 2015
Contract start31 Mar 2015
Contract end24 Mar 2016
Procedureopen
SME suitableYes
OCIDocds-b5fd17-3a91db92-adc8-11e6-9901-0019b9f3037b

description

We have a requirement to purchase 1 g of the following 5 recombinant antibodies in a custom made formulation (buffer to be defined at a later stage):

Anti-CD52 [Campath-1H], Human IgG1

Anti-CD3 epsilon [OKT-3 (muromonab)], Mouse IgG2A

Anti- Keyhole limpet hemocyanin (KLH), Mouse IgG2A

Anti-KLH, Human IgG1

Anti-KLH, Human IgG4

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
5 Mar 2015 Tender (tender) · ocds-b5fd17-3a91db92-adc8-11e6-9901-0019b9f3037b-60916-p2032
14 Sept 2015 Planning (planning) · ocds-b5fd17-c4d9686b-adc8-11e6-9901-0019b9f3037b-74063-p-1032

more from Medicines and Healthcare Products Regulatory Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.